Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogenetics
Purpose Cytogenetically normal acute myeloid leukemia (CN-AML) is a heterogeneous disease with variable clinical outcomes. The identification of potential biomarkers to better classify the patients with unfavorable prognoses who may require more aggressive therapies is an emergent demand. PRDM16 is...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2022-12-01
|
| coleção: | Hematology |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/16078454.2022.2066306 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|